Fluo Labs: The Future of Allergy Relief (212)

Episode 12 May 14, 2022 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 20

September 05, 2021 00:48:50
Episode Cover

Startup Profile: Lactiga (020)

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...

Listen

Episode 16

May 24, 2022 00:24:35
Episode Cover

ParaNano: Applying nano technology to wound care (216)

ParaNano Wound Care (PWC) solves a global problem in treatment of infection in chronic wounds: detection, notification, and early intervention. Infection in chronic wounds...

Listen

Episode 15

May 21, 2022 00:28:00
Episode Cover

CadexGenomics: Taking the Fight to Stage 4 Cancer (215)

The Cadex Genomics mission and passion is to improve the lives of cancer patients. They have developed a novel, blood-based assays for patients with...

Listen